ACV Auctions ACVA 深 沪
等待开盘 04-02 09:30:00 美东时间
4.305
+0.065
+1.53%
华盛通- 最 高4.405
- 今 开4.23
- 成交量 258.46万股
- 最 低 4.07
- 昨 收 4.24
- 总市值 7.49亿
- 52周最高 17.54
- 市盈率 静 --
- 换手率 1.48%
- 52周最低 4.065
- 委 比 -17.25%
- 总股本 1.74亿
- 历史最高 37.77
- 量 比 0.95
- 振 幅 7.90%
- 历史最低 4.065
- 每 手 1
- 风险率 3.92%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
ACV Auctions Management Team to Present at Citizens Technology Conference
ACV Auctions Management Team to Present at Citizens Technology Conference ACV Auctions Inc. said members of its management team will present at the Citizens Technology Conference on Tuesday, March 3, 2026 at 12:00 p.m. PT. A live webcast will be available at https://investors.acvauto.com/, with an a
03-02 22:01
美股大行评级 | 大摩将应用材料目标价升至432美元；潜在涨幅200.0%！维尔生物科技获巴克莱升目标价至30美元，维持"超配"评级
今日重点评级关注：巴克莱：维持Vir Biotechnology"超配"评级，目标价从26美元升至30美元；巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从10美元升至11美元
02-26 09:30
美股大行评级 | 潜在涨幅243.25%！泰利克斯制药获花旗升目标价至22.5美元，维持"买入"评级
今日重点评级关注：花旗：维持Telix Pharmaceuticals"买入"评级，目标价从22美元升至22.5美元；摩根士丹利：维持Vir Biotechnology"超配"评级，目标价从20美元升至24美元
02-25 11:03
Needham Reiterates Buy on ACV Auctions, Maintains $9 Price Target
Needham analyst Chris Pierce reiterates ACV Auctions (NYSE:ACVA) with a Buy and maintains $9 price target.
02-24 19:56
电话会总结 ｜ ACV Auctions(ACVA)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据ACV Auctions业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **Q4 2025财务表现：** - **营收**：1.84亿美元，同比增长15%，达到指引区间高端 - **调整后EBITDA**：800万美元，同比增长36%，超出指引区间高端 - **Non-GAAP净亏损**：100万美元，好于指引预期 - **销售单位**：Q4销售19.3万辆车；全年单位增长超过8.6万辆，同比增长12% **全年2025财务表现：** - **全年营收增长**：同比增长19% - **调整后EBITDA增长**：全年增长超过100%，
02-24 12:08
财报速睇 | ACV Auctions, Inc. Class A 2025财年Q4营收1.84亿美元，同比增长15.1%；归母净利润亏损0.20亿美元，同比亏损缩窄25.2%
华盛资讯2月24日讯，ACV Auctions, Inc. Class A公布2025财年Q4业绩，公司Q4营收1.84亿美元，同比增长15.1%，归母净利润亏损0.20亿美元，同比亏损缩窄25.2%。
02-24 05:49
ACV Auctions Sees FY2026 Sales $845.000M-$855.000M vs $849.566M Est
ACV Auctions (NASDAQ:ACVA) sees FY2026 sales of $845.000 million-$855.000 million vs $849.566 million analyst estimate.
02-24 05:08
ACV Q4 revenue rises 15% to USD 184 million
ACV Q4 revenue rises 15% to USD 184 million ACV said Q4 FY2025 revenue rose to USD 184 million (+15%), including marketplace and service revenue of USD 160 million (+11%). Marketplace GMV was USD 2.3 billion (+2%) and marketplace units were 192,757 (+5%). Q4 GAAP net loss was USD 20 million, while a
02-24 05:07
BRIEF-ACV Auctions Q4 Basic EPS USD -0.11
BRIEF-ACV Auctions Q4 Basic EPS USD -0.11 Feb 23 (Reuters) - ACV Auctions Q4 pretax profit USD -19.04 million. Q4 operating expenses USD 201.493 million Q4 operating income USD -17.848 million Q4 net income USD -19.561 million Q4 adjusted EBITDA USD 8 million vs. IBES estimate USD 5.86 million outlo
02-24 05:05
